Loading...

OpGen, Inc.

OPGN•NASDAQ
Healthcare
Medical - Diagnostics & Research
$23.91
$0.00(0.00%)
U.S. Market opens in 23h 5m

OpGen, Inc. (OPGN) Stock Overview

Explore OpGen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap242.7M
P/E Ratio35.19
EPS (TTM)$0.18
ROE0.78%
Fundamental Analysis

AI Price Forecasts

1 Month$22.75
3 Months$40.76
1 Year Target$2.60

OPGN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of OpGen, Inc. (OPGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.86, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.60.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.19 and a market capitalization of 242.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.96%
5-Day Change
1.74%
1-Month Change
N/A
3-Month Change
32.17%
6-Month Change
23909900.72%
Year-to-Date (YTD) Change
50.38%
1-Year Change
476.14%
3-Year Change
127.71%
5-Year Change
-94.98%
All-Time (Max) Change
-100.00%

Contact Information

https://www.opgen.com
240 813 1260
9717 Key West Avenue, Rockville, MD, 20850

Company Facts

850 Employees
IPO DateMay 5, 2015
CountryUS

Frequently Asked Questions